Tag

Cancer Test

All articles tagged with #cancer test

good-news2 years ago•8 min saved

"Revolutionary Blood Test Detects 18 Early-Stage Cancers Across Major Organs"

This week's good news includes the development of a 'gamechanger' cancer test that can identify 18 early-stage cancers, China's record-breaking renewables growth, a sharp decline in the US murder rate, positive results from a trial using a psychedelic to treat PTSD, and an increase in southern Africa's elephant population. Additionally, domestic abuse survivors in England and Wales will have access to "lifeline" payments, and Poland has halted logging in valuable forest areas. Spain welcomed its first parliamentarian with Down's syndrome, and the UK's electric vehicle infrastructure received a boost with plans to repurpose old street cabinets into charging points.

via Positive.News|

#cancer-test #conservation #good-news

business2 years ago•1 min saved

Illumina to Sell Cancer Test Developer Grail Amid Antitrust Battles

Gene-sequencing company Illumina has announced its decision to sell Grail, a cancer test developer that it acquired for $7.1 billion in 2021. This move comes after a federal appeals court largely upheld a Federal Trade Commission ruling that Illumina should unwind its deal with Grail on antitrust grounds. The sale of Grail will be executed through a third-party sale or a capital market transaction, with the goal of finalizing the deal by the end of the second quarter next year. This case is seen as a test of regulators' efforts to prevent big companies from acquiring fledgling innovators, and it may have implications for other tech giants and dominant companies in their respective fields.

via The New York Times|

#antitrust #business #cancer-test

business2 years ago•2 min saved

Biotech Company Mistakenly Informs 400 Patients They May Have Cancer

Grail, the maker of a blood test for cancer, has acknowledged that around 400 of its customers were mistakenly told last month that they might have the disease due to a software configuration issue from one of its vendors. The problem was not caused by inaccurate test results, and more than half of the people who received the letter in error had not yet had their blood drawn for the test. The vendor, PWNHealth, said it addressed the underlying problem within an hour of becoming aware of it and has implemented additional processes to ensure it does not happen again.

via The New York Times|

#business #cancer-test #grail

business2 years ago•1 min saved

Grail's Revenue Growth Impresses Amid Proxy Fight.

Illumina CEO Francis deSouza has praised the company's acquisition of Grail after the cancer test developer's revenue doubled in the last year. Grail's early screening test, which can detect over 50 types of cancer through a single blood draw, has driven the sales. However, the acquisition is the focus of a proxy fight with activist investor Carl Icahn, who has called it "disastrous" and criticized Illumina's corporate governance. Antitrust regulators in the US and Europe have also ordered Illumina to divest the $7.1 billion acquisition.

via CNBC|

#antitrust-regulators #business #cancer-test

business2 years ago

FTC Blocks Illumina's $7B Acquisition of Grail for Cancer Testing

The Federal Trade Commission (FTC) has rejected Illumina's $7 billion acquisition deal for Grail, a cancer-test developer, citing antitrust concerns. The FTC argued that the deal would harm competition in the market for multi-cancer early detection tests. Illumina has expressed disappointment with the decision and is considering its options.

via The Wall Street Journal|

#acquisition #business #cancer-test